Search
for
Sort by
Community 9
- GT20029 China Phase II Trial For AGA Reached Primary Endpoint
- PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance
- Grey Market GT20029 and Frequency of Application
- bro where tf is GT20029, Q1 2024 is over already
- Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China
- End of Hair loss ( AGA ) ? Since they produce it in china probably we don’t need to wait other 10 yrs😁
- Desensitize Follicle Sensitivity to DHT?
- DHT and 5AR respect post, it's importance within the brain
- Allopregnanolone deficiency by 5-ari inhibition (fin/dut users)